Select mid-size biotech firms by CEO compensation 2019

Select CEO compensations provided by mid-size biotech firms in 2019*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in

Use Ask Statista Research Service

Release date

September 2020



Survey time period


Number of respondents

base: 231 life sciences companies

Special properties

mid-size biotech companies

Supplementary notes

* For the report, BioPharma Dive segmented the 231 companies into four groups by number of employees: small (fewer than 200), mid-sized (200 to 999), large (1,000 to 9,999) and greater than 10,000 (giant).

This statistic is for firms in the second category: mid-sized biotech companies with 200-999 employees.

CEO compensation includes base salary, cash bonuses and long-term stock and option awards, as described in annual proxy filings.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Medical biotech industry"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.